- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05112133
Effect of Mulberry Leaf Extract on Glucose Response of a Test Meal
October 5, 2023 updated by: Société des Produits Nestlé (SPN)
The aim of this study is to test the effects of Mulberry leaf extract on glucose response of a standardized complete meal when taken just before or when mixed with the meal.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Vaud
-
Lausanne, Vaud, Switzerland, 1000
- Nestlé Clinical Research Unit
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Male and female participants
- Healthy status (based on anamnesis)
- Age between 18 and 45 years
- BMI between 20 and 29.9 kg/m2
- Ability to understand and sign an informed consent form
Exclusion Criteria:
- Pregnant or lactating women
- Major medical/surgical event in the last 3 months potentially interfering with study procedures and assessments
- Known food allergy and intolerance to test product
- Medically known cutaneous hypersensitivity to adhesives and plasters
- Alcohol intake higher than 2 servings per day. A serving is 0.4 dl of strong alcohols, 1 dl of red or white wine, or 3 dl of beer.
Smokers
Volunteer who cannot be expected to comply with the protocol
Subject having a hierarchical link with the research team members.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Control
Water administrated just before a meal
|
Oral administration
|
|
Experimental: Mulberry leaf extract before
250 mg of Mulberry leaf extract was administered before a standard meal
|
Oral administration
|
|
Experimental: Mulberry leaf extract during
250 mg of Mulberry leaf extract was administered during a standard meal
|
Oral administration
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post-prandial glucose
Time Frame: Hour 0 to hour 3 after standard meal consumption
|
Incremental area under the curve
|
Hour 0 to hour 3 after standard meal consumption
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
C max glucose
Time Frame: Hour 0 to hour 3 after standard meal consumption
|
Incremental C max
|
Hour 0 to hour 3 after standard meal consumption
|
|
T max glucose
Time Frame: Hour 0 to hour 3 after standard meal consumption
|
Incremental T max
|
Hour 0 to hour 3 after standard meal consumption
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 24, 2020
Primary Completion (Actual)
February 7, 2020
Study Completion (Actual)
February 7, 2020
Study Registration Dates
First Submitted
September 30, 2021
First Submitted That Met QC Criteria
October 27, 2021
First Posted (Actual)
November 8, 2021
Study Record Updates
Last Update Posted (Actual)
October 6, 2023
Last Update Submitted That Met QC Criteria
October 5, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 19.09 NRC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post-prandial Glycemia
-
University of Alabama at BirminghamMcCormick Science InstituteRecruitingPost-prandial Glucose ResponseUnited States
-
BioglaneCompletedReduction of Post-prandial Glycaemic ResponseUnited Kingdom
-
Cedars-Sinai Medical CenterCompletedPost-prandial Intestinal RatesUnited States
-
Unity Health TorontoCompletedPost Prandial Blood GlucoseCanada
-
St. Boniface HospitalUniversity of Manitoba; Agriculture and Agri-Food CanadaActive, not recruiting
-
Oslo Metropolitan UniversityUniversity of Oslo; Nofima; Mills DACompletedGut Microbiota | Satiety | Post Prandial Blood GlucoseNorway
-
Aga Khan UniversityThe Searle Company Limited PakistanNot yet recruitingPost Prandial Distress Syndrome | Functioanl Dyspepsia
-
University of ManitobaNot yet recruitingFeasibility Pilot Study | Post Prandial Blood Glucose
-
Yale UniversityCompletedPost-Prandial Hyperglycemia | Post-Prandial HypoglycemiaUnited States
-
St Mary's University CollegeCompletedPost-prandial GlycaemiaUnited Kingdom
Clinical Trials on Water
-
Polyclinic of the Hospitaller Brothers of St. John...Enrolling by invitationLow Back Pain | Performance Measures | Fatigue RecoveryHungary
-
Essentia Water, LLCHealth Onvector Inc.Completed
-
University of ManitobaCompleted
-
University Hospital, MontpellierCompletedHealthy | Heat ExposureFrance
-
Imam Abdulrahman Bin Faisal UniversityThe Saline Water Conversion Corporation Research Institute at Al-Jubail,...CompletedDiabetes Mellitus | Glucose, High Blood | PatientsSaudi Arabia
-
University of FloridaWithdrawnWeight Loss | Appetitive Behavior | Energy Intake | Water
-
Singapore General HospitalUnknown
-
University of Novi Sad, Faculty of Sport and Physical...Dom Zdravlja NisCompleted
-
Pharos University in AlexandriaActive, not recruiting
-
Institute of Progressive MedicineActive, not recruiting